🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Donn G. Wishka

National Cancer Institute

ORCID: 0009-0004-9563-3261
MedicineComputer ScienceBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.685Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0267
Top 29%
0.685DataRank
Top 29%24 citations

Mark W. Kunkel, Stephen L. White, Donn G. Wishka, Omar D. Lopez, Lori Bowles +16 more

Papers

Driven by 4 papers — median percentile 35. Top paper: “Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource”.

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0267
Top 29%
0.685DataRank
Top 29%24 citations

Mark W. Kunkel, Stephen L. White, Donn G. Wishka, Omar D. Lopez, Lori Bowles +16 more

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0738
N/A
0DataRank · unranked
11 citations

Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman +9 more

Data from F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

(2023)10.1158/1535-7163.c.6543264.v1
Top 100%
0DataRank
Top 100%0 citations

Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman +9 more

A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the Network

Molecules(2025)10.3390/molecules30092001
N/A
0DataRank · unranked
2 citations

Sarbjit Singh, Kiran K. Mangalaparthi, Smitha Kizhake, Lelisse T. Umeta, Donn G. Wishka +4 more